Companies / Industrials
GE
GE Aerospace
Aerospace & Defense
Aerospace & DefenseAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health76
Growth83
Profitability80
Cash generation65
Balance sheet54
Dilution control95
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)15.9%Revenue growth (FY)18.5%Revenue CAGR (3y)16.3%Gross margin—Operating margin—Net margin19.0%Free cash flow margin15.8%R&D / revenue3.4%Stock comp / revenue0.7%Net debt / operating cash flow0.95xCurrent ratio1.04Diluted share count change-2.4%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $56.5B | $29.1B | $35.3B | $38.7B | $45.9B |
| Net income | -$6.3B | $336M | $9.5B | $6.6B | $8.7B |
| Operating cash flow | $3.5B | $5.9B | $5.2B | $4.7B | $8.5B |
| Capital expenditure | $1.2B | $1.4B | $862M | $1.0B | $1.3B |
| Free cash flow | $2.2B | $4.5B | $4.3B | $3.7B | $7.3B |
| R&D | $1.7B | $808M | $1.0B | $1.3B | $1.6B |
| Stock-based comp | $305M | $143M | $192M | $286M | $325M |
| Buybacks | $107M | $1.0B | $1.2B | $5.8B | $7.6B |
| Cash | $15.8B | $15.8B | $15.2B | $13.6B | $12.4B |
| Total debt | $30.8B | $20.3B | $20.9B | $19.3B | $20.5B |
| Equity | $40.3B | $33.7B | $27.4B | $19.3B | $18.7B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.